Metsera bid exit gives boost to Novo Nordisk shares

Metsera

10/11/2025 08:17

** Shares in Denmark's Novo Nordisk NOVOb.CO rise around 3% after it dropped its bid for obesity drug developer Metsera MTSR.O

** Metsera accepted the offer from Pfizer PFE.N late on Friday, while Novo said on Saturday it would not be making an increased offer and said it would exit the race

** "Metsera is out of sight for investors, and it sounds more negative than it probably is," Nordnet analyst Per Hansen says

 (Reporting by Elviira Luoma)

 ((Elviira.luoma@thosmonreuters.com))